Edmund Haislmaier

Contributor

Edmund F. Haislmaier is an expert in health care policy and markets at The Heritage Foundation. He is frequently asked to assist federal and state lawmakers in designing and drafting health reform proposals and legislation.

BIOGRAPHY

An expert in health care policy and markets at The Heritage Foundation, Edmund F. Haislmaier frequently is asked to help lawmakers design and draft specific reforms to the health system.

As the Preston A. Wells, Jr. Senior Research Fellow, Health and Welfare Policy, for the Grover M. Hermann Center for the Federal Budget, Haislmaier’s expertise includes health care tax policy, Medicare, Medicaid, foreign health systems, pharmaceuticals and health care price controls.

Haislmaier works on related bills with both state and federal legislators, particularly alternatives to the Affordable Care Act, popularly called Obamacare. He has developed innovative strategies for states to create consumer-centered health insurance markets by using their authority to regulate insurance.

Under his design, employers may opt to enroll workers in a state health insurance “exchange,” through which each worker then buys coverage of his or her choice. Employers avoid the difficulties of administering a traditional “one size fits all” group plan, while employees pick their own coverage and take it from job to job. No one loses current tax preferences or other benefits of employer-sponsored insurance.

This approach is a key element of Utah’s health care reforms, adopted in 2009. And in recent years, 15 other states have asked Haislmaier and his colleagues in Heritage’s Center for Health Policy Studies to help develop consumer-focused solutions for their troubled health systems.

In the past 25 years, he has developed particular expertise in the regulation of health insurance markets, the tax treatment of health benefits and pharmaceutical policy issues. He has published extensively on those and other health policy topics.

Haislmaier is in demand as a conference speaker and has testified before numerous federal and state legislative committees. He is a frequent guest on radio and television news and talk shows. His commentaries have been published in The Washington Times, New York Post, and National Review Online, among many others.

Before rejoining Heritage in 2005 as a Research Fellow, Haislmaier worked as a Health Policy Consultant from 1998 to 2004 and was Director of Health Care Policy in Pfizer Inc.’s Corporate Strategic Planning and Policy division from 1994 to 1997.

He originally came to Heritage in 1987 as the think tank’s first policy analyst for health care. He was named Senior Policy Analyst in 1994, then Senior Research Fellow in 2007.

Haislmaier is a member of the board of directors of the National Center for Public Policy Research. He holds a bachelor’s degree in History from St. Mary’s College in Maryland.

Summary

Ed Haislmaier is a health policy expert at The Heritage Foundation who helps lawmakers develop reforms for the health care system.

He has worked extensively on health insurance, Medicare, Medicaid, and alternatives to the Affordable Care Act.

His consumer-focused health insurance model became a major part of Utah’s health care reforms and influenced efforts in other states.

LATEST

  • opinion

    Don’t Expand Obamacare, Make Health Care Affordable Again

    Nina Owcharenko Schaefer | Edmund Haislmaier
    With the government shutdown over, it’s time to get back to work on fixing America’s health care. Even Obamacare supporters now admit their health plan has failed. Despite promises of decreasing premiums, the sad truth has come to light. Over 10 years in, Obamacare has become part of the problem, not the solution. Premiums keep…
    View More
  • opinion

    Biden-Harris Admin’s Medicare Shock for Seniors

    Edmund Haislmaier | Joel White
  • opinion

    Does America Really Have a ‘Medical Debt Crisis’?

    Mark Howell | Edmund Haislmaier
  • opinion

    Why New Federal Health Care Benefit Mandates Must Be Avoided

    Nina Owcharenko Schaefer | Edmund Haislmaier
  • opinion

    An Rx for the Persistent Problem of Prescription Drug Shortages

    Edmund Haislmaier
  • opinion

    House-Passed ‘Right to Contraception’ Bill Creates Problems, Doesn’t Solve Them

    Edmund Haislmaier | Melanie Israel
  • opinion

    Extending Enhanced Obamacare Subsidies Would Be Costly, Ineffective

    Edmund Haislmaier
  • opinion

    What Congress Shouldn’t (and Should) Do About Cost of Insulin

    Edmund Haislmaier
  • opinion

    Rx for Disaster: Democrats’ Bill Shows How Not to Get Affordable, Innovative Prescription Drugs

    Edmund Haislmaier
  • opinion

    Adding Dental Benefits to Medicare Is a Solution in Search of a Problem

    Edmund Haislmaier | Abigail Slagle
  • opinion

    To Prepare for COVID-19 Vaccine, Let’s Ensure Manufacturing Capacity Will Meet Demand

    Edmund Haislmaier
  • opinion

    How FDA’s Emergency Powers Speed Drugs, Other Supplies to Fight Coronavirus

    Edmund Haislmaier
  • opinion

    How Congress Can Reduce Obamacare Premiums

    Doug Badger | Edmund Haislmaier
  • opinion

    Obamacare Is Shrinking the Individual Health Insurance Market

    Edmund Haislmaier
  • opinion

    In Order to Lower Drug Prices, 3 Areas the Government Should Address

    Edmund Haislmaier | Nina Owcharenko Schaefer
  • opinion

    Congress Should Provide Obamacare Opt-Outs, Not Bailouts

    Edmund Haislmaier | Robert Moffit